Skip to main content

INGR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ingredion (INGR)

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2026 / Ingredion Incorporated (NYSE: INGR) shares fell after the Company used its third-quarter 2026 results to cut its full-year adjusted EPS outlook to $9.25-$9.70. Ingredion also said it now expects adjusted operating income to decline by a mid-teens percentage. If you bought INGR and are holding a loss, or already sold at one, your rights as a shareholder did not end with the sell-off. Shareholders who lost money on INGR are encouraged to submit their INGR loss details now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Under the new outlook, Ingredion expects full-year 2026 sales to be flat. Management cited softer U.S./Canada demand and higher manufacturing and input costs as drivers of the reduced forecast.

Levi & Korsinsky is investigating potential securities law violations on behalf of Ingredion shareholders. The investigation includes whether the Company's earlier outlook statements adequately accounted for these demand and cost pressures. Investors who purchased INGR and suffered losses may be eligible to participate whether or not they still own the shares. There is no upfront cost to have those losses evaluated.

If you lost money on your Ingredion investment, find out whether you may be able to recover, or call Joseph E. Levi, Esq. at (212) 363-7500.

Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com

Frequently Asked Questions About the INGR Investigation

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Ingredion Incorporated made materially false or misleading statements regarding its earnings outlook and the demand and cost pressures affecting its business. The stock price declined when the Company reported third-quarter 2026 results and lowered its full-year 2026 adjusted EPS outlook to $9.25-$9.70.

Q: When did Ingredion allegedly mislead investors? A: The investigation concerns statements made before the Company's third-quarter 2026 earnings update and reduced outlook. These statements allegedly caused investors to purchase securities at inflated prices.

Q: Who is eligible to participate in the INGR investigation? A: Investors who purchased INGR stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What do INGR investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my INGR shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought INGR and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis. Any attorneys' fees and expenses are subject to court approval.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

SOURCE: Levi & Korsinsky, LLP



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.17
-4.70 (-1.74%)
AAPL  355.63
+7.12 (2.04%)
AMD  552.90
+37.69 (7.32%)
BAC  50.67
-0.01 (-0.02%)
GOOG  290.63
+5.71 (2.00%)
META  628.77
-12.62 (-1.97%)
MSFT  521.12
-12.03 (-2.26%)
NVDA  173.73
+4.84 (2.87%)
ORCL  128.38
+10.40 (8.82%)
TSLA  390.84
+11.06 (2.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.